AbbVie Inc - Asset Resilience Ratio

Latest as of December 2025: 0.02%

AbbVie Inc (ABBV) has an Asset Resilience Ratio of 0.02% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read AbbVie Inc debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

$28.00 Million

Cash + Short-term Investments

Total Assets

$133.96 Billion

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2010–2025)

This chart shows how AbbVie Inc's Asset Resilience Ratio has changed over time. See ABBV book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down AbbVie Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see AbbVie Inc stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$28.00 Million	0.02%
Total Liquid Assets	$28.00 Million	0.02%

Asset Resilience Insights

Limited Liquidity: AbbVie Inc maintains only 0.02% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

AbbVie Inc Industry Peers by Asset Resilience Ratio

Compare AbbVie Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Pfizer Inc SA:PFIZ34	Drug Manufacturers - General	7.18%
CSPC Pharmaceutical Group Limited F:CVG	Drug Manufacturers - General	4.64%
Aurora Optoelectronics Co Ltd SHG:600666	Drug Manufacturers - General	5.89%
Shandong Keyuan Pharmaceutical Co. Ltd. A SHE:301281	Drug Manufacturers - General	6.44%
Dimed S.A. Distribuidora de Medicamentos SA:PNVL3	Drug Manufacturers - General	10.10%
Pfizer Inc NYSE:PFE	Drug Manufacturers - General	7.18%
Merck & Company Inc NYSE:MRK	Drug Manufacturers - General	14.06%
Firebrick Pharma Ltd AU:FRE	Drug Manufacturers - General	0.29%

Annual Asset Resilience Ratio for AbbVie Inc (2010–2025)

The table below shows the annual Asset Resilience Ratio data for AbbVie Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.02%	$28.00 Million	$133.96 Billion	0.00pp
2024-12-31	0.02%	$31.00 Million	$135.16 Billion	+0.02pp
2023-12-31	0.00%	$2.00 Million	$134.71 Billion	-0.02pp
2022-12-31	0.02%	$28.00 Million	$138.81 Billion	-0.04pp
2021-12-31	0.06%	$84.00 Million	$146.53 Billion	+0.04pp
2020-12-31	0.02%	$30.00 Million	$150.56 Billion	--
2019-12-31	0.00%	$0.00	$89.11 Billion	--
2018-12-31	1.30%	$772.00 Million	$59.35 Billion	+0.61pp
2017-12-31	0.69%	$486.00 Million	$70.79 Billion	-1.31pp
2016-12-31	2.00%	$1.32 Billion	$66.10 Billion	+1.99pp
2015-12-31	0.02%	$8.00 Million	$53.05 Billion	-0.08pp
2014-12-31	0.09%	$26.00 Million	$27.51 Billion	-0.93pp
2013-12-31	1.03%	$300.00 Million	$29.20 Billion	-6.66pp
2012-12-31	7.68%	$2.08 Billion	$27.01 Billion	+4.48pp
2011-12-31	3.21%	$626.00 Million	$19.52 Billion	+3.20pp
2010-12-31	0.01%	$1.13 Million	$21.13 Billion	--

pp = percentage points

About AbbVie Inc

NYSE:ABBV USA Drug Manufacturers - General

Market Cap

$365.30 Billion

Market Cap Rank

#37 Global

#26 in USA

Share Price

$206.60

Change (1 day)

-2.23%

52-Week Range

$177.44 - $244.38

All Time High

$244.38